Strs Ohio reduced its position in shares of CME Group Inc. (NASDAQ:CME) by 3.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 209,129 shares of the financial services provider’s stock after selling 7,883 shares during the period. Strs Ohio owned 0.06% of CME Group worth $26,191,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Huntington National Bank boosted its stake in CME Group by 4.7% in the first quarter. Huntington National Bank now owns 851 shares of the financial services provider’s stock worth $100,000 after buying an additional 38 shares in the last quarter. Coconut Grove Bank boosted its stake in CME Group by 95.7% in the first quarter. Coconut Grove Bank now owns 900 shares of the financial services provider’s stock worth $107,000 after buying an additional 440 shares in the last quarter. Whittier Trust Co. boosted its stake in CME Group by 12.6% in the first quarter. Whittier Trust Co. now owns 1,030 shares of the financial services provider’s stock worth $122,000 after buying an additional 115 shares in the last quarter. Parallel Advisors LLC boosted its stake in CME Group by 4.1% in the first quarter. Parallel Advisors LLC now owns 1,084 shares of the financial services provider’s stock worth $128,000 after buying an additional 43 shares in the last quarter. Finally, RidgeWorth Capital Management LLC boosted its stake in CME Group by 55.5% in the first quarter. RidgeWorth Capital Management LLC now owns 1,138 shares of the financial services provider’s stock worth $135,000 after buying an additional 406 shares in the last quarter. Hedge funds and other institutional investors own 83.25% of the company’s stock.
CME Group Inc. (CME) opened at 125.39 on Friday. The firm has a market capitalization of $42.62 billion, a price-to-earnings ratio of 25.60 and a beta of 0.73. CME Group Inc. has a 1-year low of $98.95 and a 1-year high of $127.96. The stock has a 50 day moving average price of $123.50 and a 200 day moving average price of $121.16.
CME Group (NASDAQ:CME) last issued its earnings results on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.03. CME Group had a return on equity of 7.61% and a net margin of 46.05%. The firm had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. During the same quarter in the previous year, the company posted $1.14 earnings per share. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. Analysts predict that CME Group Inc. will post $4.80 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $2.64 dividend on an annualized basis and a yield of 2.11%. CME Group’s dividend payout ratio (DPR) is currently 53.99%.
COPYRIGHT VIOLATION NOTICE: This report was originally published by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.com-unik.info/2017/08/19/strs-ohio-has-26-19-million-position-in-cme-group-inc-nasdaqcme-updated-updated.html.
A number of analysts recently commented on the company. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research report on Friday. Royal Bank Of Canada lifted their price objective on CME Group from $130.00 to $135.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 20th. Jefferies Group LLC reissued a “buy” rating and issued a $134.00 price target (up from $128.00) on shares of CME Group in a research note on Monday, July 17th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. Finally, UBS AG reissued a “buy” rating and issued a $134.00 price target (down from $136.00) on shares of CME Group in a research note on Monday, June 5th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $131.63.
In other CME Group news, insider Sunil Cutinho sold 10,265 shares of the business’s stock in a transaction dated Wednesday, May 24th. The stock was sold at an average price of $117.85, for a total value of $1,209,730.25. Following the transaction, the insider now owns 21,690 shares in the company, valued at $2,556,166.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kathleen M. Cronin sold 8,125 shares of the business’s stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $127.35, for a total value of $1,034,718.75. Following the completion of the transaction, the insider now owns 38,174 shares in the company, valued at approximately $4,861,458.90. The disclosure for this sale can be found here. Insiders sold 91,085 shares of company stock worth $11,242,896 in the last 90 days. Corporate insiders own 0.61% of the company’s stock.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
What are top analysts saying about CME Group Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CME Group Inc. and related companies.